Showing 14,021 - 14,040 results of 102,029 for search '(( i step decrease ) OR ( 5 ((((teer decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.36s Refine Results
  1. 14021
  2. 14022

    Adenylate cyclase activation does not cause translocation of PKC Apl II in response to 5HT in Sf9 cells. by Carole A. Farah (336422)

    Published 2016
    “…<p><b>A)</b> Sf9 cells were cotransfected with mRFP-PKC Apl II along with either eGFP-5HT<sub>4Apl</sub> (n = 17), eGFP-5HT<sub>7Apl</sub> (n = 15) or eGFP-5HT<sub>2Apl</sub> (n = 9). …”
  3. 14023

    Typical fit of V Kα spectrum using only five scaling parameters, yielding two calibration points (V Kα<sub>1</sub> and V Kα<sub>2</sub> which constrain the spectrometer dispersion... by C T Chantler (557430)

    Published 2013
    “…The peak energy of the titanium Kβ spectral profile is found to be 4931.966 ± 0.022 eV prior to instrumental broadening. This 4.5 ppm result decreases the uncertainty over the past literature by a factor of 2.6 and is 2.4 standard deviations from the previous standard. …”
  4. 14024

    OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on <i>Acinetobacter baumannii</i> by Ming-Feng Lin (768243)

    Published 2015
    “…The bacteria-killing effect of LL-37 on <i>A</i>. <i>baumannii</i> was more efficient compared to other AMPs, including human ß–defensin 3 (hBD3) and histatin 5 (Hst5). …”
  5. 14025
  6. 14026
  7. 14027
  8. 14028

    Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer by Tamar Kavlashvili (849072)

    Published 2016
    “…Analysis of the Cancer Genome Atlas (TCGA) database of endometrial tumors identified an inverse correlation between PR and Myc mRNA levels, with a corresponding inverse correlation between PR and Myc downstream transcriptional targets SRD5A1, CDK2 and CCNB1. …”
  9. 14029
  10. 14030
  11. 14031

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…<div><p>Background</p><p>Dyslipidemia as a risk factor of cardiovascular disease is common especially in HIV-infected patients who are using protease inhibitors (PIs) including atazanavir. …”
  12. 14032
  13. 14033

    Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model by Zhuo-Long Wang (673199)

    Published 2014
    “…</p><p>Methods</p><p>BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. …”
  14. 14034

    Anthelmintics Derived from the Kinase Inhibitor SGI-1776 for the Treatment of Gastrointestinal Worm Infections by Mostafa A. Elfawal (22430138)

    Published 2025
    “…We demonstrate the efficacy of optimized compound <b>50</b> as a new oral anthelmintic, which demonstrated better gut restriction properties and significantly reduced the fecundity of T. muris whipworm adults in infected mice. …”
  15. 14035
  16. 14036

    Summary of changes in gene expression in P19[shβ-cat] cultures compared to same-day P19[shControl] cultures after differentiation in DMSO, with and without RA (− = decrease;+ = inc... by Jacob Wong (382569)

    Published 2013
    “…<p>Summary of changes in gene expression in P19[shβ-cat] cultures compared to same-day P19[shControl] cultures after differentiation in DMSO, with and without RA (− = decrease;+ = increase; NC = No change; NE = not expressed; ND = not determined; * = Enhanced or recovered gene expression due to RA treatment)(Data from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0057501#pone-0057501-g003" target="_blank">Figs. 3</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0057501#pone-0057501-g005" target="_blank">5</a>).…”
  17. 14037

    Table 3_Genetic association of ACE2 rs2285666 (C>T) and rs2106809 (A>G) and susceptibility to SARS-CoV-2 infection among the Ghanaian population.docx by Alexander Owusu Boakye (13716966)

    Published 2025
    “…Among females, those with the T allele of ACE2 rs2285666 had a 38% decreased susceptibility to SARS-CoV-2 infection under the dominant [adjusted odds ratio (aOR) = 0.62; 95%CI = 0.45–0.85, P = 0.003] and heterozygous advantage models (aOR = 0.62; 95%CI = 0.45–0.86, P = 0.004), after adjusting for confounders, but not thee recessive model (aOR = 0.41; 95%CI = 0.03–5.22, P = 0.490). …”
  18. 14038

    Table 1_Genetic association of ACE2 rs2285666 (C>T) and rs2106809 (A>G) and susceptibility to SARS-CoV-2 infection among the Ghanaian population.docx by Alexander Owusu Boakye (13716966)

    Published 2025
    “…Among females, those with the T allele of ACE2 rs2285666 had a 38% decreased susceptibility to SARS-CoV-2 infection under the dominant [adjusted odds ratio (aOR) = 0.62; 95%CI = 0.45–0.85, P = 0.003] and heterozygous advantage models (aOR = 0.62; 95%CI = 0.45–0.86, P = 0.004), after adjusting for confounders, but not thee recessive model (aOR = 0.41; 95%CI = 0.03–5.22, P = 0.490). …”
  19. 14039

    Table 2_Genetic association of ACE2 rs2285666 (C>T) and rs2106809 (A>G) and susceptibility to SARS-CoV-2 infection among the Ghanaian population.docx by Alexander Owusu Boakye (13716966)

    Published 2025
    “…Among females, those with the T allele of ACE2 rs2285666 had a 38% decreased susceptibility to SARS-CoV-2 infection under the dominant [adjusted odds ratio (aOR) = 0.62; 95%CI = 0.45–0.85, P = 0.003] and heterozygous advantage models (aOR = 0.62; 95%CI = 0.45–0.86, P = 0.004), after adjusting for confounders, but not thee recessive model (aOR = 0.41; 95%CI = 0.03–5.22, P = 0.490). …”
  20. 14040

    Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria by Jennie Lin (671926)

    Published 2014
    “…Unadjusted and multivariable analyses of eGFR association with log-transformed lipid parameters in incremental linear and logistic regression models (with eGFR 90 mL/min/1.73 m<sup>2</sup> as a cut-point) were performed.</p><p>Results</p><p>Mild GFR impairment (eGFR 60–90 mL/min/1.73 m<sup>2</sup>, median urinary ACR 5.25 mg/g) was associated with higher log-transformed Lp(a) values (OR 1.17, p = 0.005) and with clinically atherogenic Lp(a) levels above 30 mg/dL (OR 1.35, p = 0.013) even after full adjustment for demographics, medications, metabolic parameters, and albuminuria. …”